| Efficacy and safety of moclobemide compared with imipramine in the treatment of major depressive disorder. Double-blind multicenter study, Austria. | |
| | |
MedLine Citation:
|
PMID: 2089087 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
In a double-blind, 4-week, prospective, randomized multicenter (17 centers) study we checked on the efficacy, tolerability and safety of moclobemide (300-600 mg/d) compared to imipramine (100-200 mg/d) in parallel groups of patients with a Major Depressive Episode (DSM III). The mean % reduction of the HAMD at the end of treatment was 51.7 in the moclobemide group and 52.1 in the imipramine group. The percentage of patients in whom efficacy was globally judged as "good" or "very good" was 62% in the moclobemide group and 60% in the imipramine group. There was no statistically significant difference in the efficacy in both groups but in some factors there was a trend for a better amelioration favoring moclobemide. The final overall physician's judgement of tolerability was "good" or "very good" in 83% of moclobemide patients and in 74% of imipramine patients. Adverse events were reported or observed in 56% of moclobemide patients and in 69% of imipramine patients. The number of mild, moderate and severe adverse events was higher in the imipramine group with a total of 286 versus 189. There was a statistically high significant difference considering the tolerability favoring moclobemide again. In this project the basic goal to find a substance with at least the same efficacy but a much better tolerability for sure got fulfilled. |
| | |
Authors:
|
G F Hebenstreit; M Loidl; U Baumhackl; B Gallhofer; C Geretsegger; E Radmayr; M Saletu; W Schöny; M Stabl |
Related Documents
:
|
15323587 - A double-blind, randomized, placebo-controlled trial of quetiapine addition in patients... 9178167 - The riluzole early access programme: descriptive analysis of 844 patients in france. al... 15356567 - Randomized placebo-controlled trial comparing desloratadine and montelukast in monother... 10707717 - Roxatidine in duodenal ulcer. 11583747 - Trial of invasive versus medical therapy in elderly patients with chronic symptomatic c... 22091577 - Postoperative delirium and functional decline after noncardiac surgery. |
Publication Detail:
|
Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial |
Journal Detail:
|
Title: Journal of neural transmission. Supplementum Volume: 32 ISSN: 0303-6995 ISO Abbreviation: J. Neural Transm. Suppl. Publication Date: 1990 |
Date Detail:
|
Created Date: 1991-05-29 Completed Date: 1991-05-29 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0425126 Medline TA: J Neural Transm Suppl Country: AUSTRIA |
Other Details:
|
Languages: eng Pagination: 177-84 Citation Subset: IM |
Affiliation:
|
NO Landes-Nervenklinik, Amstetten/Mauer, Switzerland. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Adult Aged Aged, 80 and over Austria Benzamides / adverse effects, therapeutic use* Depressive Disorder / drug therapy*, psychology Double-Blind Method Female Humans Imipramine / adverse effects, therapeutic use* Male Middle Aged Moclobemide Monoamine Oxidase Inhibitors / therapeutic use* Prospective Studies Psychiatric Status Rating Scales |
| Chemical | |
Reg. No./Substance:
|
0/Benzamides; 0/Monoamine Oxidase Inhibitors; 50-49-7/Imipramine; 71320-77-9/Moclobemide |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Does moclobemide stimulate melatonin synthesis as the other selective MAO-A inhibitors do?
Next Document: Psychometric alterations in treatment with the MAO-A-inhibitor moclobemide.